1,000
Participants
Start Date
May 12, 2020
Primary Completion Date
February 1, 2024
Study Completion Date
February 1, 2024
Observational study
Observational study of this study, no interventions involved
Anhui Cancer Hospital, Hefei
Maanshan People's Hospital, Maanshan
Hainan General Hospital, Haikou
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Tumor Hospital of Harbin Medical University, Harbin
Henan Cancer Hospital, Zhengzhou
Inner Mongolia Autonomous Region Cancer Hospital, Hohhot
Liaoning Cancer Hospital, Shenyang
Zhongshan Hospital, Shanghai
Shanxi Provincial Cancer Hospital, Taiyuan
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital), Xi’an
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
INDUSTRY